Doctors probe blood test flaw that could put kidney patients at risk during chemo
NCT ID NCT07124403
Summary
This study aims to understand if a standard blood test used to determine safe chemotherapy doses works correctly for patients who also have kidney problems. Researchers will measure a specific enzyme activity in the blood cells of about 740 patients with breast or digestive cancers, some of whom have kidney impairment. The goal is to figure out if the test results are misleading for these patients, which could help prevent dangerous side effects from chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.